<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37070132</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.</ArticleTitle><Pagination><StartPage>e2997</StartPage><MedlinePgn>e2997</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2997</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.2997</ELocationID><Abstract><AbstractText Label="BACKGROUND">Spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) were two major motor neuron diseases with similar symptoms and poor outcomes. This study aimed to identify potential biomarkers in disease monitoring and differential diagnosis of adult SMA patients with sporadic ALS patients.</AbstractText><AbstractText Label="METHODS">This was a pilot study with ten adult SMA patients and ten ALS patients consecutively enrolled during hospitalization. Serum and cerebrospinal fluid (CSF) samples were collected for assessment of neurofilament light (NFL) and phosphorylated neurofilament heavy chain (pNFH). Serum creatine kinase (CK) and creatinine (Cr) were also compared between groups. The receiver operating characteristic (ROC) curves were used to identify differentiated values among ALS and SMA patients.</AbstractText><AbstractText Label="RESULTS">Serum Cr, CSF NFL, and CSF pNFH levels of ALS patients were significantly higher than those of the adult SMA patients (p&#xa0;&lt;&#xa0;.01). Serum CK and Cr were strongly correlated with baseline ALSFRS-R scores in SMA patients (p&#xa0;&lt;&#xa0;.001). The ROC curves revealed an area under the curve (AUC) of 0.94 in serum Cr with a cut-off value of 44.5&#xa0;&#x3bc;mol/L (Sensitivity 90%, Specificity 90%). AUC from the ROC curve of CSF NFL and CSF pNFH were 1.0 and 0.84, with cut-off values of 1275 pg/mL and 0.395&#xa0;ng/mL, respectively (Sensitivity and Specificity of 100% and 100% in CSF NFL; Sensitivity and Specificity of 90% and 80% in CSF pNFH).</AbstractText><AbstractText Label="CONCLUSION">CSF NFL and pNFH might be useful biomarkers for differential diagnosis of adult SMA and ALS.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Yue</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiao-Han</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Hai-Tao</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dong-Chao</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xun-Zhe</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ming-Sheng</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><Identifier Source="ORCID">0000-0002-5369-1541</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016900">Neurofilament Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007382" MajorTopicYN="N">Intermediate Filaments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016900" MajorTopicYN="N">Neurofilament Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">neurofilament</Keyword><Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword></KeywordList><CoiStatement>The authors report there are no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37070132</ArticleId><ArticleId IdType="pmc">PMC10175988</ArticleId><ArticleId IdType="doi">10.1002/brb3.2997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arnold, F. J. , &amp; Merry, D. E. (2019). Molecular mechanisms and therapeutics for Sbma/Kennedy's disease. Neurotherapeutics, 16, 928&#x2013;947. 10.1007/s13311-019-00790-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00790-9</ArticleId><ArticleId IdType="pmc">PMC6985201</ArticleId><ArticleId IdType="pubmed">31686397</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar, M. , Zhang, L. , Wang, L. , Granit, V. , Statland, J. , Barohn, R. , Swenson, A. , Ravits, J. , Jackson, C. , Burns, T. M. , Trivedi, J. , Pioro, E. P. , Caress, J. , Katz, J. , Mccauley, J. L. , Rademakers, R. , Malaspina, A. , Ostrow, L. W. , &amp; Wuu, J. (2020). Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for Als. Neurology, 95, e59&#x2013;e69. 10.1212/WNL.0000000000009559</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009559</ArticleId><ArticleId IdType="pmc">PMC7371380</ArticleId><ArticleId IdType="pubmed">32385188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccanti, M. , Pozzilli, V. , Cambieri, C. , Libonati, L. , Onesti, E. , Frasca, V. , Fiorini, I. , Petrucci, A. , Garibaldi, M. , Palma, E. , Bendotti, C. , Fabbrizio, P. , Trolese, M. C. , Nardo, G. , &amp; Inghilleri, M. (2020). Creatine kinase and progression rate in amyotrophic lateral sclerosis. Cells, 9, 1174. 10.3390/cells9051174</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051174</ArticleId><ArticleId IdType="pmc">PMC7291088</ArticleId><ArticleId IdType="pubmed">32397320</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaytow, H. , Huang, Y.&#x2010;T. , Gillingwater, T. H. , &amp; Faller, K. M. E. (2018). The role of survival motor neuron protein (Smn) in protein homeostasis. Cellular and Molecular Life Sciences, 75, 3877&#x2013;3894. 10.1007/s00018-018-2849-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2849-1</ArticleId><ArticleId IdType="pmc">PMC6182345</ArticleId><ArticleId IdType="pubmed">29872871</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley, L. H. , Nijssen, J. , Frost&#x2010;Nylen, J. , &amp; Hedlund, E. (2016). Cross&#x2010;disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology. The Journal of Comparative Neurology, 524, 1424&#x2013;1442. 10.1002/cne.23917</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23917</ArticleId><ArticleId IdType="pmc">PMC5063101</ArticleId><ArticleId IdType="pubmed">26502195</ArticleId></ArticleIdList></Reference><Reference><Citation>Darras, B. T. , Crawford, T. O. , Finkel, R. S. , Mercuri, E. , De Vivo, D. C. , Oskoui, M. , Tizzano, E. F. , Ryan, M. M. , Muntoni, F. , Zhao, G. , Staropoli, J. , Mccampbell, A. , Petrillo, M. , Stebbins, C. , Fradette, S. , Farwell, W. , &amp; Sumner, C. J. (2019). Neurofilament as a potential biomarker for spinal muscular atrophy. Annals of Clinical and Translational Neurology, 6, 932&#x2013;944. 10.1002/acn3.779</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.779</ArticleId><ArticleId IdType="pmc">PMC6530526</ArticleId><ArticleId IdType="pubmed">31139691</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wel, B. , De Schaepdryver, M. , Poesen, K. , &amp; Claeys, K. G. (2022). Biochemical and clinical biomarkers in adult Sma 3&#x2013;4 patients treated with nusinersen for 22 months. Annals of Clinical and Translational Neurology, 9, 1241&#x2013;1251. 10.1002/acn3.51625</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51625</ArticleId><ArticleId IdType="pmc">PMC9380134</ArticleId><ArticleId IdType="pubmed">35833245</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wolf, F. , Ghanbari, M. , Licher, S. , Mcrae&#x2010;Mckee, K. , Gras, L. , Weverling, G. J. , Wermeling, P. , Sedaghat, S. , Ikram, M. K. , Waziry, R. , Koudstaal, W. , Klap, J. , Kostense, S. , Hofman, A. , Anderson, R. , Goudsmit, J. , &amp; Ikram, M. A. (2020). Plasma tau, neurofilament light chain and amyloid&#x2010;beta levels and risk of dementia; a population&#x2010;based cohort study. Brain, 143, 1220&#x2013;1232. 10.1093/brain/awaa054</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa054</ArticleId><ArticleId IdType="pmc">PMC7174054</ArticleId><ArticleId IdType="pubmed">32206776</ArticleId></ArticleIdList></Reference><Reference><Citation>Didonna, A. , &amp; Opal, P. (2019). The role of neurofilament aggregation in neurodegeneration: Lessons from rare inherited neurological disorders. Molecular Neurodegeneration, 14, 19. 10.1186/s13024-019-0318-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0318-4</ArticleId><ArticleId IdType="pmc">PMC6524292</ArticleId><ArticleId IdType="pubmed">31097008</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster, L. A. , &amp; Salajegheh, M. K. (2019). Motor neuron disease: Pathophysiology, diagnosis, and management. The American Journal of Medicine, 132, 32&#x2013;37. 10.1016/j.amjmed.2018.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2018.07.012</ArticleId><ArticleId IdType="pubmed">30075105</ArticleId></ArticleIdList></Reference><Reference><Citation>Freigang, M. , Wurster, C. D. , Hagenacker, T. , Stolte, B. , Weiler, M. , Kamm, C. , Schreiber&#x2010;Katz, O. , Osmanovic, A. , Petri, S. , Kowski, A. , Meyer, T. , Koch, J. C. , Cordts, I. , Deschauer, M. , Lingor, P. , Aust, E. , Petzold, D. , Ludolph, A. C. , Falkenburger, B. , &#x2026; G&#xfc;nther, R. (2021). Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment. Annals of Clinical and Translational Neurology, 8, 1049&#x2013;1063. 10.1002/acn3.51340</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51340</ArticleId><ArticleId IdType="pmc">PMC8108420</ArticleId><ArticleId IdType="pubmed">33792208</ArticleId></ArticleIdList></Reference><Reference><Citation>Habets, L. E. , Bartels, B. , Asselman, F. &#x2010;L. , Hooijmans, M. T. , Van Den Berg, S. , Nederveen, A. J. , Van Der Pol, W. L. , &amp; Jeneson, J. A. L. (2022). Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy. Brain, 145, 1422&#x2013;1435. 10.1093/brain/awab411</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab411</ArticleId><ArticleId IdType="pmc">PMC9128825</ArticleId><ArticleId IdType="pubmed">34788410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, J. &#x2010;K. , Jha, N. N. , Feng, Z. , Faleiro, M. R. , Chiriboga, C. A. , Wei&#x2010;Lapierre, L. , Dirksen, R. T. , Ko, C. &#x2010;P. , &amp; Monani, U. R. (2020). Muscle&#x2010;specific Smn reduction reveals motor neuron&#x2010;independent disease in spinal muscular atrophy models. Journal of Clinical Investigation, 130, 1271&#x2013;1287. 10.1172/JCI131989</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI131989</ArticleId><ArticleId IdType="pmc">PMC7269591</ArticleId><ArticleId IdType="pubmed">32039917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, L. , Valdivia, D. O. , Simon, C. M. , Hassinan, C. W. , Delestr&#xe9;e, N. , Ramos, D. M. , Park, J. H. , Pilato, C. M. , Xu, X. , Crowder, M. , Grzyb, C. C. , King, Z. A. , Petrillo, M. , Swoboda, K. J. , Davis, C. , Lutz, C. M. , Stephan, A. H. , Zhao, X. , Weetall, M. , &#x2026; Sumner, C. J. (2021). Impaired prenatal motor axon development necessitates early therapeutic intervention in severe Sma. Science Translational Medicine, 13, eabb6871. 10.1126/scitranslmed.abb6871</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abb6871</ArticleId><ArticleId IdType="pmc">PMC8208236</ArticleId><ArticleId IdType="pubmed">33504650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhle, J. , Kropshofer, H. , Haering, D. A. , Kundu, U. , Meinert, R. , Barro, C. , Dahlke, F. , Tomic, D. , Leppert, D. , &amp; Kappos, L. (2019). Blood neurofilament light chain as a biomarker of Ms disease activity and treatment response. Neurology, 92, e1007&#x2013;e1015. 10.1212/WNL.0000000000007032</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007032</ArticleId><ArticleId IdType="pmc">PMC6442011</ArticleId><ArticleId IdType="pubmed">30737333</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre, S. , &amp; Sarret, C. (2020). Pathogenesis and therapeutic targets in spinal muscular atrophy (Sma). Archives de Pediatrie, 27, 7S3&#x2013;7S8. 10.1016/S0929-693X(20)30269-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0929-693X(20)30269-4</ArticleId><ArticleId IdType="pubmed">33357595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi, V. , Querin, G. , Ziff, O. J. , Zampedri, L. , Martinelli, I. , Heller, C. , Foiani, M. , Bertolin, C. , Lu, C. &#x2010;H. , Malik, B. , Allen, K. , Rinaldi, C. , Zetterberg, H. , Heslegrave, A. , Greensmith, L. , Hanna, M. , Soraru, G. , Malaspina, A. , &amp; Fratta, P. (2019). Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology, 92, e1205&#x2013;e1211. 10.1212/WNL.0000000000007097</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007097</ArticleId><ArticleId IdType="pmc">PMC6511101</ArticleId><ArticleId IdType="pubmed">30787165</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercuri, E. , Pera, M. C. , Scoto, M. , Finkel, R. , &amp; Muntoni, F. (2020). Spinal Muscular Atrophy &#x2010; Insights and Challenges in the Treatment Era. Nat Rev Neurol, 16, 706&#x2013;715. 10.1038/s41582-020-00413-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00413-4</ArticleId><ArticleId IdType="pubmed">33057172</ArticleId></ArticleIdList></Reference><Reference><Citation>Milella, G. , Introna, A. , D'errico, E. , Fraddosio, A. , Scaglione, G. , Morea, A. , Ucci, M. , Ruggieri, M. , Mastrapasqua, M. , Megna, M. , Puntillo, F. , &amp; Simone, I. L. (2021). Cerebrospinal fluid and clinical profiles in adult type 2&#x2013;3 spinal muscular atrophy patients treated with nusinersen: An 18&#x2010;month single&#x2010;centre experience. Clinical Drug Investigation, 41, 775&#x2013;784. 10.1007/s40261-021-01071-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40261-021-01071-0</ArticleId><ArticleId IdType="pmc">PMC8390404</ArticleId><ArticleId IdType="pubmed">34389971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollenhauer, B. , Dakna, M. , Kruse, N. , Galasko, D. , Foroud, T. , Zetterberg, H. , Schade, S. , Gera, R. G. , Wang, W. , Gao, F. , Frasier, M. , Chahine, L. M. , Coffey, C. S. , Singleton, A. B. , Simuni, T. , Weintraub, D. , Seibyl, J. , Toga, A. W. , Tanner, C. M. , &#x2026; Graham, D. (2020). Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression. Movement Disorders, 35, 1999&#x2013;2008. 10.1002/mds.28206</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28206</ArticleId><ArticleId IdType="pmc">PMC8017468</ArticleId><ArticleId IdType="pubmed">32798333</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash, A. L. , Burns, K. J. , Chardon, W. J. , Kothary, R. , &amp; Parks, J. R. (2016). Spinal muscular atrophy: More than a disease of motor neurons? Current Molecular Medicine, 16, 779&#x2013;792. 10.2174/1566524016666161128113338</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566524016666161128113338</ArticleId><ArticleId IdType="pubmed">27894243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitz, E. , Smitka, M. , Schallner, J. , Akg&#xfc;n, K. , Ziemssen, T. , Hagen, M. , &amp; T&#xfc;ngler, V. (2021). Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children. Annals of Clinical and Translational Neurology, 8, 2013&#x2013;2024. 10.1002/acn3.51449</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51449</ArticleId><ArticleId IdType="pmc">PMC8528467</ArticleId><ArticleId IdType="pubmed">34482646</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson, B. , Gendron, T. F. , &amp; Staff, N. P. (2018). Amyotrophic lateral sclerosis: An update for 2018. Mayo Clinic Proceedings, 93, 1617&#x2013;1628. 10.1016/j.mayocp.2018.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Panagiotou, P. , Kanaka&#x2010;Gantenbein, C. , &amp; Kaditis, A. G. (2022). Changes in ventilatory support requirements of spinal muscular atrophy (Sma) patients post gene&#x2010;based therapies. Children (Basel), 9, 1207. 10.3390/children9081207</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9081207</ArticleId><ArticleId IdType="pmc">PMC9406975</ArticleId><ArticleId IdType="pubmed">36010097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross, L. F. , &amp; Kwon, J. M. (2019). Spinal muscular atrophy: Past, present, and future. Neoreviews, 20, e437&#x2013;e451. 10.1542/neo.20-8-e437</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/neo.20-8-e437</ArticleId><ArticleId IdType="pubmed">31371553</ArticleId></ArticleIdList></Reference><Reference><Citation>Schorling, D. C. , Pechmann, A. , &amp; Kirschner, J. (2020). Advances in treatment of spinal muscular atrophy&#x2014;New phenotypes, new challenges, new implications for care. Journal of Neuromuscular Diseases, 7, 1&#x2013;13. 10.3233/JND-190424</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-190424</ArticleId><ArticleId IdType="pmc">PMC7029319</ArticleId><ArticleId IdType="pubmed">31707373</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldrop, M. A. , Karingada, C. , Storey, M. A. , Powers, B. , Iammarino, M. A. , Miller, N. F. , Alfano, L. N. , Noritz, G. , Rossman, I. , Ginsberg, M. , Mosher, K. A. , Broomall, E. , Goldstein, J. , Bass, N. , Lowes, L. P. , Tsao, C. &#x2010;Y. , Mendell, J. R. , &amp; Connolly, A. M. (2020). Gene therapy for spinal muscular atrophy: Safety and early outcomes. Pediatrics, 146, e20200729. 10.1542/peds.2020-0729</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0729</ArticleId><ArticleId IdType="pubmed">32843442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurster, C. D. , Steinacker, P. , G&#xfc;nther, R. , Koch, J. C. , Lingor, P. , Uzelac, Z. , Witzel, S. , Wollinsky, K. , Winter, B. , Osmanovic, A. , Schreiber&#x2010;Katz, O. , Al Shweiki, R. , Ludolph, A. C. , Petri, S. , Hermann, A. , &amp; Otto, M. (2020). Neurofilament light chain in serum of adolescent and adult Sma patients under treatment with nusinersen. Journal of Neurology, 267, 36&#x2013;44. 10.1007/s00415-019-09547-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09547-y</ArticleId><ArticleId IdType="pubmed">31552549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, A. , Rao, M. V. , Veeranna, &amp; Nixon, R. A. (2017). Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harbor Perspectives in Biology, 9, a018309. 10.1101/cshperspect.a018309</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018309</ArticleId><ArticleId IdType="pmc">PMC5378049</ArticleId><ArticleId IdType="pubmed">28373358</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>